Racepinephrine: Package Insert and Label Information

RACEPINEPHRINE- racepinephrine hydrochloride aerosol
Nephron Pharmaceuticals Corporation

Drug Facts

Active ingredient (in each 0.5 ml)

Racepinephrine, USP 11.25 mg (as 13.5 mg of Racepinephrine HCl, USP).




For temporary relief of mild symptoms of intermittent asthma:

  • Wheezing
  • Tightness of chest
  • Shortness of breath


Asthma alert

Because asthma may be life threatening, see a doctor if you:

  • Are not better in 20 minutes
  • Get worse
  • Need more than 12 inhalations in 24 hours
  • Use more than 9 inhalations in 24 hours for 3 or more days a week
  • Have more than 2 asthma attacks in a week

These may be signs that your asthma is getting worse.

Allergy alert

Contains potassium metabisulfite and sodium metabisulfite, sulfites that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

Do not use

  • Unless a doctor said you have asthma
  • If you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains a MAOI, ask a doctor or pharmacist before taking this product.
  • If product is brown in color or cloudy

Ask a doctor before use if you have

  • Ever been hospitalized for asthma
  • Heart disease
  • High blood pressure
  • Diabetes
  • Thyroid disease
  • Seizures
  • Narrow angle glaucoma
  • A psychiatric or emotional condition
  • Trouble urinating due to an enlarged prostate gland

Ask a doctor or pharmacist before use if you are

  • Taking prescription drugs for asthma, obesity, weight control, depression, or psychiatric or emotional conditions.
  • Taking any drug that contains phenylephrine, pseudoephedrine, ephedrine, or caffeine (such as for allergy, cough-cold, or pain).

Stop use and ask a doctor if

  • Your asthma is getting worse (See Asthma alert)
  • You have difficulty sleeping
  • You have a rapid heartbeat
  • You have tremors, nervousness, or seizure

When using this product

Your blood pressure or heart rate may go up. This could increase your risk of heart attack or stroke, which may cause death.

  • Your risk of heart attack or stroke increases if you:
    • Have a history of high blood pressure or heart disease
    • Take this product more frequently or take more than the recommended dose.
    • Avoid foods or beverages that contain caffeine
    • Avoid dietary supplements containing ingredients reported or claimed to have a stimulant effect.
  • If pregnant or breast-feeding, ask a health professional before use.
  • Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.


  • Do not use more than directed
  • The ingredient is used in an aqueous solution at a concentration equivalent to 1 percent epinephrine.
  • For use in a nebulizer:
    Add 0.5 ml (approximately 10 drops) of solution to nebulizer.
  • Adults and children 4 years of age and over:
    1 to 3 inhalations not more often than every 3 hours. Start with one inhalation, then wait at least 1 minute. If symptoms do not improve, use once more. Do not exceed more than 3 inhalations over a 3 hour period.
    Do not use more than 12 inhalations in 24 hours.
    The use of this product by children should be supervised by an adult.
  • Children under 4 years of age: ask a doctor.

Other Information

  • Protect from light. Avoid excessive heat. Protect from freezing.
  • Store between 2°C and 25°C (36°F and 77°F).
  • How Supplied: S2 ® Racepinephrine Inhalation Solution, 2.25% is supplied in 15 ml amber glass, multi-dose bottles.
    NDC 0487-5910-01 15 ml amber glass, multi-dose bottle

Inactive Ingredients

Benzoic acid, chlorobutanol, potassium metabisulfite, propylene glycol, sodium chloride, sodium metabisulfite, water for injection.



Monday through Friday, 8:00 a.m. to 5:00 p.m. (Eastern Standard Time).

Manufactured By:

Orlando, FL 32811


NDC 0487-5910-01


S2 ®

Inhalation Solution,



Manufactured By:


Orlando, FL 32811

15 ml (1/2 fl. oz.)

Principal Display Panel -- 15 ml Bottle Carton
(click image for full-size original)
racepinephrine hydrochloride aerosol
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NHRIC:0487-5910
Route of Administration RESPIRATORY (INHALATION) DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Racepinephrine Hydrochloride (Racepinephrine) Racepinephrine 11.25 mg in 0.5 mL
Inactive Ingredients
Ingredient Name Strength
Benzoic acid
potassium metabisulfite
propylene glycol
sodium chloride
sodium metabisulfite
# Item Code Package Description Multilevel Packaging
1 NHRIC:0487-5910-01 12 CARTON in 1 BOX contains a CARTON
1 1 BOTTLE, GLASS in 1 CARTON This package is contained within the BOX (0487-5910-01) and contains a BOTTLE, GLASS
1 15 mL in 1 BOTTLE, GLASS This package is contained within a CARTON and a BOX (0487-5910-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
EXPORT ONLY 08/12/1992
Labeler — Nephron Pharmaceuticals Corporation (783905201)
Name Address ID/FEI Operations
Nephron Pharmaceuticals Corporation 783905201 MANUFACTURE (0487-5910), ANALYSIS (0487-5910)

Revised: 02/2014 Nephron Pharmaceuticals Corporation

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2020. All Rights Reserved.